Fagron
Отворен
СекторЗдравеопазване
24.55 -0.81
Преглед
Промяна на цената на акция
24 ч
Минимум
24.4
Максимум
24.85
Приходи | -99K 45M |
|---|---|
Продажби | -98K 476M |
P/E Средно за сектора | 19.194 49.052 |
Дивидентна доходност | 1.69 |
Марж на печалбата | 9.55 |
Служители | 4,193 |
EBITDA | 11M 98M |
Препоръки | Купи |
|---|---|
12-месечна прогноза | +20.59% upside |
Дивидентна доходност Средно за сектора | 1.69% 2.36% |
|---|---|
Следващи печалби | 30.07.2026 г. |
Пазарна капитализация | 116M 1.7B |
|---|---|
Предишно отваряне | 25.36 |
Предишно затваряне | 24.55 |
Настроения в новините
By Acuity
50%
50%
146 / 342 Класиране в Healthcare
Fagron Графика
Миналото представяне не гарантира бъдещи резултати.
Относно Fagron
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.